Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Subgroup analyses with special reference to the effect of antiplatelet agents in acute coronary syndromes.

Aronson D.

Thromb Haemost. 2014 Jul 3;112(1):16-25. doi: 10.1160/TH13-09-0801. Epub 2014 Mar 6. Review.

PMID:
24599493
2.

Advances in antiplatelet treatment for acute coronary syndromes.

Eshaghian S, Shah PK, Kaul S.

Heart. 2010 May;96(9):656-61. doi: 10.1136/hrt.2009.185983. Epub 2009 Nov 11. Review.

PMID:
19910292
3.

New antiplatelet agents in the treatment of acute coronary syndromes.

Sabouret P, Taiel-Sartral M.

Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11. Review.

4.

New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.

Sinhal AR, Aylward PE.

Clin Ther. 2013 Aug;35(8):1064-8. doi: 10.1016/j.clinthera.2013.07.429. Review.

PMID:
23973039
5.

Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.

Serebruany VL, DiNicolantonio JJ.

Thromb Haemost. 2013 Jul;110(1):5-10. doi: 10.1160/TH13-02-0142. Epub 2013 Jun 7.

PMID:
23743577
6.

Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromes.

Norgard NB, Dinicolantonio JJ.

Postgrad Med. 2013 Jul;125(4):91-102. doi: 10.3810/pgm.2013.07.2682. Review.

PMID:
23933898
7.

Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor.

De Servi S, Navarese EP, D'Urbano M, Savonitto S.

Curr Med Res Opin. 2011 Nov;27(11):2117-22. doi: 10.1185/03007995.2011.618492. Epub 2011 Sep 15.

PMID:
21919581
8.

Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndrome.

Coleman CI, Limone BL.

Am J Cardiol. 2013 Aug 1;112(3):355-62. doi: 10.1016/j.amjcard.2013.03.036. Epub 2013 Apr 27.

PMID:
23631863
9.

Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes.

Aronow WS.

Postgrad Med. 2013 Jan;125(1):51-8. doi: 10.3810/pgm.2013.01.2624. Review.

PMID:
23391671
10.

Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.

Packard KA, Campbell JA, Knezevich JT, Davis EM.

Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review.

PMID:
22392457
11.

Development and clinical use of prasugrel and ticagrelor.

Ahmad S, Storey RF.

Curr Pharm Des. 2012;18(33):5240-60. Review.

PMID:
22724412
12.

[Novel agents in antiplatelet therapy].

Ağırbaşlı M, Güvenç H, Cinçin A.

Turk Kardiyol Dern Ars. 2010 Jul;38(5):369-78. Review. Turkish.

13.

Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?

Kowalczyk M, Banach M, Mikhailidis DP, Hannam S, Rysz J.

Med Sci Monit. 2009 Dec;15(12):MS24-30. Review.

PMID:
19946242
14.

Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes.

Huber K, Lip GY.

Thromb Haemost. 2013 Jul;110(1):11-3. doi: 10.1160/TH13-06-0453. Epub 2013 Jun 7. No abstract available.

PMID:
23743615
15.

Antiplatelets in acute coronary syndrome: personal perspectives.

Marcucci R, Cenci C, Cioni G, Lombardi A, Giusti B, Gensini GF.

Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1487-96. doi: 10.1586/erc.12.153. Review.

PMID:
23253274
16.

New antiplatelet agents: why they are needed.

Franchini M, Mannucci PM.

Eur J Intern Med. 2009 Dec;20(8):733-8. doi: 10.1016/j.ejim.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19892299
17.

Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome. Agents, indications, issues to consider in clinical practice.

Sibbing D, Orban M, Massberg S.

Hamostaseologie. 2013;33(1):9-15. doi: 10.5482/HAMO-12-12-0022. Epub 2013 Jan 8. Review.

PMID:
23299202
18.

Update on antiplatelet therapy in acute coronary syndromes: what do new drugs bring into clinical practice?

Heras M, del Río A.

Am J Cardiovasc Drugs. 2009;9 Suppl 1:13-7. doi: 10.2165/1153164-S0-000000000-00000. Review.

PMID:
20000883
19.

Antiplatelet options for secondary prevention in acute coronary syndromes.

Silvain J, Cayla G, O'Connor SA, Collet JP, Montalescot G.

Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1403-15. doi: 10.1586/erc.11.139. Review.

PMID:
22059790
20.

[Platelet inhibitors in clinical practice].

Gebhard C, Beer J.

Ther Umsch. 2012 Nov;69(11):617-29. doi: 10.1024/0040-5930/a000339. Review. German.

PMID:
23117664

Supplemental Content

Support Center